Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Potential new analgesic agent from SmithKline Beecham

Sep. 20, 1996

Stroke Update

Sep. 13, 1996

Progress in CNS drug development at Daiichi

Sep. 13, 1996

Chugai's CNS pipeline

Sep. 13, 1996

CNS research at Toyama

Sep. 13, 1996

Antioxidants isolated by Japanese researchers

Sep. 13, 1996

Neuronal calcium channel antagonists for stroke

Sep. 13, 1996

New cholinergic channel activators described by Abbott

Sep. 13, 1996

Inhibitors of C1r for Alzheimer's disease

Sep. 13, 1996

Lilly reports new treatment for attention deficit/hyperactivity disorder

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.